Literature DB >> 19952750

Vaccine safety: current systems and recent findings.

Melinda Wharton1.   

Abstract

PURPOSE OF REVIEW: An understanding of vaccine safety is important for all immunization providers, who have responsibilities to identify, report, and prevent adverse events. RECENT
FINDINGS: New analytic methods can provide more rapid information on adverse events compared with traditional observational studies. Some adverse events following vaccination are preventable. Syncope is increasingly recognized postvaccination and may be associated with severe injury or death. Both human and system factors should be addressed to prevent vaccine administration errors. Ongoing basic science and clinical research is critical to improved understanding of vaccine safety. A recent study suggests that many cases of encephalopathy following whole-cell pertussis vaccine were due to severe myoclonic epilepsy of infancy, a severe seizure disorder associated with mutations of the sodium channel gene SCN1A.
SUMMARY: Vaccine safety requires prelicensure evaluation, postlicensure surveillance and investigation, addressing preventable adverse events, reconsideration of vaccine policy as understanding of risks and benefits changes, and ongoing research to better understand the response to vaccination and the pathogenesis of adverse events.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19952750     DOI: 10.1097/MOP.0b013e3283350425

Source DB:  PubMed          Journal:  Curr Opin Pediatr        ISSN: 1040-8703            Impact factor:   2.856


  4 in total

1.  Improving the safety of vaccine delivery.

Authors:  Huw P Evans; Alison Cooper; Huw Williams; Andrew Carson-Stevens
Journal:  Hum Vaccin Immunother       Date:  2016-02-22       Impact factor: 3.452

Review 2.  Overview of the Clinical Consult Case Review of adverse events following immunization: Clinical Immunization Safety Assessment (CISA) network 2004-2009.

Authors:  S Elizabeth Williams; Nicola P Klein; Neal Halsey; Cornelia L Dekker; Roger P Baxter; Colin D Marchant; Philip S LaRussa; Robert C Sparks; Jerome I Tokars; Barbara A Pahud; Laurie Aukes; Kathleen Jakob; Silvia Coronel; Howard Choi; Barbara A Slade; Kathryn M Edwards
Journal:  Vaccine       Date:  2011-07-27       Impact factor: 3.641

3.  Consumer reporting of adverse events following immunization (AEFI): identifying predictors of reporting an AEFI.

Authors:  Adriana Parrella; Michael Gold; Annette Braunack-Mayer; Peter Baghurst; Helen Marshall
Journal:  Hum Vaccin Immunother       Date:  2014-01-09       Impact factor: 3.452

Review 4.  Current Challenges and Achievements in Maternal Immunization Research.

Authors:  Flor M Munoz
Journal:  Front Immunol       Date:  2018-03-06       Impact factor: 7.561

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.